Abstract
Allergic contact dermatitis (ACD) is an example of an undesirable consequence of our immune system. The adaptive immune system has evolved mainly as a host defense against infection and against malignant cells, but in the case of ACD it also reacts to environmental chemicals. The contact allergic reaction has two main phases: sensitization and elicitation [1–3]. During the sensitization phase the individual acquires a specific immunological memory at the T-cell level to the contact sensitizer. Upon renewed contact with the sensitizing substance, irrespective of where on the skin costume this contact takes place, this often lifelong memory will mount an immune response, resulting in eczema. The immune response is a delayed-type hypersensitivity or type-IV hypersensitivity reaction as classified by Coombs and Gell [4], since it takes more than 12 h to become evident visually and peaks at about 24–72 h. The molecular mechanisms that decide whether an individual will become sensitized or not are still largely unknown.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Polak L (1980) Immunological aspects of contact sensitivity. Karger, Basel (Monographs in Allergy)
Turk JL (1980) Delayed hypersensitivity, 3rd edn. North-Holland, Amsterdam, The Netherlands
Scheper RJ, von Blomberg BME (1995) Cellular mechanisms in allergic contact dermatitis. In: Rycroft RJG, Menne T, Frosch PJ (eds) Textbook of contact dermatitis, 2nd edn. Springer-Verlag, Berlin Heidelberg New York, pp 11–27
Coombs RRA, Gell PGH (1975) Classification of allergic reactions for clinical hypersensitivity and disease. In: Gell PGH, Coombs RRA, Lachman R (eds) Clinical aspects of immunology, 3rd edn. Oxford Blackwell Scientific, London, pp 761–781
Botham PA, Rattray NJ, Walsh ST, Riley EJ (1987) Control of the immune response to contact sensitizing chemicals by cutaneous antigen-presenting cells. Br J Dermatol 117:1–9
Schuler G (ed) (1991) Epidermal Langerhans cells. CRC Press, Boca Raton
Emilson A, Scheynius A (1995) Quantitative and three-dimensional analysis of human Langerhans cells in epidermal sheets and vertical skin sections. J Histochem Cytochem 43: 993–998
Shelley WB, Juhlin L (1976) Langerhans cells form a reticuloepithelial trap for external contact antigens. Nature 261:46–47
Silberger-Sinakin I, Thorbecke GJ, Baer RL, et al (1976) Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 25:137–151
Kripke ML, Munn CG, Jeevan A, et al (1990) Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833–2838
Frey JR, Wenk P (1957) Experimental studies on the pathogenesis of contact eczema in the guinea pig. Int Arch Allergy 11: 81–100
Marchal G, Seman M, Milon M, et al (1982) Local adoptive transfer of skin delayed type hypersensitivity initiated by a single T lymphocyte. J Immunol 129:954–958
Streilein JW (1983) Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 80:12–16
Bos JD, Zonneveld I, Das PK, et al (1987) The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 88:569–573
Mackay CR (1993) Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 5:423–427
Ager A (1994) Lymphocyte recirculation and homing: roles of adhesion molecules and chemoattractants. Trends Cell Biol 4: 326–333
Picker LJ, Kishimoto TK, Smith CW, et al (1991) ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 349: 796–799
Babi LFS, Picker LJ, Soler MTP, et al (1995) Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 181: 1935–1940
McCluskey RT, Benacerraf B, McCluskey JW (1963) Studies on the specificity of the cellular infiltrate in delayed hypersensitivity reactions. J Immunol 90:466–477
Scheynius A, Fischer T, Forsum U, et al (1984) Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol 55: 81–90
Brasch J, Burgard J, Sterry W (1992) Common pathogenetic pathways in allergic and irritant contact dermatitis. J Invest Dermatol 98:166–170
Scheynius A, Fischer T (1986) Phenotypic difference between allergic and irritant patch test reactions in man. Contact Dermatitis 14: 297–302
Basham TY, Nickoloff BJ, Merigan TC, et al (1984) Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. J Invest Dermatol 83:88–90
Scheynius A, Johansson C, van der Meide PH (1986) In vivo induction of la antigens on rat keratinocytes by y-interferon. Br J Dermatol 115: 543–549
Forsum U, Claesson K, Hjelm E, et al (1985) Class II transplantation antigens: Distribution in tissues and involvement in disease. Scand J Immunol 21: 389–396
Suitters AJ, Lampert IA (1982) Expression of la antigen on epidermal keratinocytes is a consequence of cellular immunity. Br J Exp Pathol 63:207–213
Scheynius A, Tjernlund U (1984) Human keratinocytes express HLA-DR antigens in the tuberculin reaction. Scand J Immunol 19:141–147
Skoglund C, Scheynius A, Holmdahl R, et al (1988) Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against y-interferon. Clin Exp Immunol 71:428–432
Skoglund C, Scheynius A (1990) Effects of interferon-y treatment on the cutaneous DTH reaction in rats. Arch Dermatol Res 282: 318–324
Skoglund C, Scheynius A, Söder O, et al (1989) Effects on rat T-helper cell proliferation by syngeneic epidermal cells exposed to IFN-y in vivo. Immunology 66:190–195
Gaspari AA, Jenkins MK, Katz SI (1988) Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness for hapten-specific TH 1 cells. J Immunol 141: 2216–2220
Nickoloff BJ, Mitra RC, Green J, et al (1993) Accessory cell function of keratinocytes for superantigens. J Immunol 150:2148–2159
Katz SI (1993) The skin as an immunological organ: allergic contact dermatitis as a paradigm. J Dermatol 20: 593–603
Nickoloff BJ, Turka LA (1994) Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 15:464–469
Langerhans P (1868) Ueber die Nerven der menschlichen Haut. Virchows Arch Pathol Anat 44: 325–337
36.Birbeck MS, Breathnach AS, Everall JD (1961) An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 37: 51–64
Kashihara M, Ueda M, Horiguchi Y, et al (1986) A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol 87:602–607
Mommaas AM, Koning F (1995) Immunoelectron microscopic analysis of major histocompatibility class II expression on human Langerhans cells. In: Moll H (ed) The im- mune functions of epidermal Langerhans cells. Springer-Verlag, Berlin Heidelberg New York, pp 73–85
Tang A, Amagai M, Granger LG, et al (1993) Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361: 82–85
Blauvelt A, Katz SI, Udey MC (1995) Human Langerhans cells express E-cadherin. J Invest Dermatol 104: 293–296
Schwarzenberger K, Udey MC (1996) Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 106: 553–558
Shimada S, Caughman SW, Sharrow SO, et al (1987) Enhanced antigen-presenting capacity of cultured Langerhans cells is associated with markedly increased expression of la antigen. J Immunol 139:2551–2555
Aiba S, Katz SI (1990) Phenotypic and functional characteristics of in vivo activated Langerhans cells. J Immunol 145:2791–2796
Scheynius A, Klareskog L, Forsum U, et al (1982) Enrichment of epidermal Langerhans cells: studies with a monolayer technique and flow cytometry sorting. J Invest Dermatol 78:452–455
Caux C, Dezutter-Dambuyant C, Schmittt D, et al (1992) GM-CSF and TNF-a cooperate in the generation of dendritic Langerhans cells. Nature 360: 258–261
Peters JH, Gieseler R, Thiele B, Steinbach F (1996) Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today 17:273–278
Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425–434
Jenkins MK, Johnson JG (1993) Molecules involved in T-cell costimulation. Curr Opin Immunol 5: 361–367
Symington FW, Brady W, Linsley PS (1993) Expression and function of B7 on human epidermal Langerhans cells. J Immunol 150:1286–1295
Yokozeki H, Katayama I, Ohki O, et al (1996) Functional CD86 (B7–2/B70) on cultured human Langerhans cells. J Invest Dermatol 106:147–153
Claesson-Welsh L, Scheynius A, Tjernlund U, et al (1986) Cell surface expression of invariant y-chain of class II histocompatibility antigens in human skin. J Immunol 136: 484–490
Germain RN (1995) MHC-associated antigen processing, presentation, and recognition. Adolescence, maturity, and beyond. Immunologist 3:185–190
Sloan VS, Cameron P, Porter G, et al (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802–806
54.Knop J (1993) Mechanisms in contact dermatitis. In: Burgdorf WHC, Katz SI (eds) Dermatology, progress and perspectives. Parthenon Public Group Inc., New York, pp 120–127
Romagnoli P, Labhardt AM, Sinigaglia F (1991) Selective interaction of Ni with an MHC- bound peptide. EMBO J 10:1303–1306
Martin S, Weltzien HU (1994) T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol 104:10–16
Balkwill FR, Burke F (1989) The cytokine network. Immunology Today 10: 302–330
Schwarz T, Luger TA (1992) Pharmacology of cytokines in the skin. In: Muhktar H (ed) Pharmacology of the skin. CRC Press, Boca Raton, pp 283–314
Kimber I (1994) Cytokines and regulation of allergic sensitization to chemicals. Toxicology 93:1–11
Kondo S, Pastore S, Shivji GM, et al (1994) Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymphokine Cytokine Res 13: 367–375
Enk AH, Katz SI (1992) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A 89:1398–1402
Ozawa H, Nakagawa S, Tagami H, et al (1996) Interleukin-/? and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441–445
Gueniche A, Viae J, Lizard G, et al (1994) Effect of nickel on the activation state of normal human keratinocytes through interleukin 1 and intercellular adhesion molecule 1 expression. Br J Dermatol 131: 250–256
Mosmann TR, Cherwinski H, Bond MW, et al (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357
Kapsenberg M, Jansen H, Bos J, et al (1992) Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol 4: 788–793
Cher DJ, Mosmann TR (1987) Two types of murine T helper cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138: 3688–3694
Kelso A (1995) Thl and Th2 subsets: paradigms lost? Immunol Today 16:374–379
Everson MP, McDuffie DS, Lemak DG, et al (1996) Dendritic cells from different tissues induce production of different T cell cytokine profiles. J Leukoc Biol 59:494–498
Chase MW (1946) Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 61:257–259
Battisto JR, Miller J (1962) Immunologic unresponsiveness produced in adult guinea pigs by parental introduction of minute quantities of hapten or protein antigen. Proc Soc Exp Biol Med 111: 111–115
Toews GB, Bergstresser PR, Streilein JW, et al (1980) Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 124:445–453
Tang A, Udey MC (1991) Inhibition of epidermal Langerhans cell function by low-dose ultraviolet B radiation. J Immunol 146: 3347–3355
Elmets CA, Bergstresser PR, Tigelaar RE, et al (1983) Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low-dose ultraviolet radiation. J Exp Med 158: 781–794
Scheynius A, Camp RL, Pure E (1993) Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J Immunol 150:655–663
Scheynius A, Camp RL, Pure E (1996) Unresponsiveness to 2,4-dinitro-l-fluorobenzene after treatment with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1 during sensitization. J Immunol 156:1804–1809
Camp RL, Scheynius A, Johansson C, et al (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178: 497–507
Miiller G, Saloga T, Germann I, et al (1994) Identification and induction of human kera- tinocyte IL-12. J Clin Invest 94:1799–1805
Riemann H, Schwarz A, Grabbe S, et al (1996) Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol 156: 1799–1803
Mekori YA, Karin N, Gottesman G, et al (1990) Tolerance to experimental contact sensitivity induced by T cell vaccination. Eur J Immunol 20: 2083- 2087
Dolhain RJEM, Elferink BG, Leow A, et al (1995) T-cell vaccination in patients with nickel allergic contact dermatitis. J Invest Dermatol 105:143–144
Hosoi J, Murphy GF, Egan CL, et al (1993) Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159–163
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scheynius, A. (1998). Immunological Aspects. In: Lepoittevin, JP., Basketter, D.A., Goossens, A., Karlberg, AT. (eds) Allergic Contact Dermatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80331-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-80331-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80333-8
Online ISBN: 978-3-642-80331-4
eBook Packages: Springer Book Archive